BSPM - Biostar Pharmaceuticals Stock Price, News & Analysis

$1.81 -0.01 (-0.55 %)
(As of 11/24/2017 04:00 PM ET)
Previous Close$1.82
Today's Range$1.73 - $1.90
52-Week Range$1.18 - $4.30
Volume29,713 shs
Average Volume78,938 shs
Market Capitalization$4.80 million
P/E Ratio2.6
Dividend YieldN/A
Beta1.85

About Biostar Pharmaceuticals (NASDAQ:BSPM)

Biostar Pharmaceuticals logoBiostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The Company offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The Company's products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people. The Company's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BSPM
CUSIPN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio0.19%
Quick Ratio0.14%

Price-To-Earnings

Trailing P/E Ratio2.6
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.38 million
Price / Sales2.01
Cash FlowN/A
Price / CashN/A
Book Value$13.70 per share
Price / Book0.13

Profitability

Trailing EPS$0.70
Net Income$-5,690,000.00
Net MarginsN/A
Return on Equity2.59%
Return on Assets2.25%

Miscellaneous

Employees200
Outstanding Shares2,640,000

Frequently Asked Questions for Biostar Pharmaceuticals (NASDAQ:BSPM)

What is Biostar Pharmaceuticals' stock symbol?

Biostar Pharmaceuticals trades on the NASDAQ under the ticker symbol "BSPM."

How were Biostar Pharmaceuticals' earnings last quarter?

Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) announced its quarterly earnings results on Wednesday, November, 15th. The company reported ($0.50) EPS for the quarter. During the same quarter in the prior year, the business posted ($3.12) EPS. View Biostar Pharmaceuticals' Earnings History.

Who are some of Biostar Pharmaceuticals' key competitors?

Who are Biostar Pharmaceuticals' key executives?

Biostar Pharmaceuticals' management team includes the folowing people:

  • Ronghua Wang, Chairman of the Board, President, Chief Executive Officer
  • Xiaojuan Zhai, Chief Financial Officer
  • , Bio & Compensation - 
  • Zhenghong Wang, Chief Operating Officer
  • Shuang Gong, Secretary of Board
  • Qinghua Liu, Director
  • Leung King-Fai, Independent Director
  • Haipeng Wu, Independent Director

How do I buy Biostar Pharmaceuticals stock?

Shares of Biostar Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biostar Pharmaceuticals' stock price today?

One share of Biostar Pharmaceuticals stock can currently be purchased for approximately $1.81.

How big of a company is Biostar Pharmaceuticals?

Biostar Pharmaceuticals has a market capitalization of $4.80 million and generates $2.38 million in revenue each year. The company earns $-5,690,000.00 in net income (profit) each year or $0.70 on an earnings per share basis. Biostar Pharmaceuticals employs 200 workers across the globe.

How can I contact Biostar Pharmaceuticals?

Biostar Pharmaceuticals' mailing address is NO. 588 SHIJI XI AVENUE, XIANYANG SHAANXI PROVINCE F4, 712046. The company can be reached via phone at 011-86-29-3368-6638.


MarketBeat Community Rating for Biostar Pharmaceuticals (BSPM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  53
MarketBeat's community ratings are surveys of what our community members think about Biostar Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Biostar Pharmaceuticals (NASDAQ:BSPM)

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: SellSellSellN/A
Consensus Rating Score: 1.001.001.00N/A
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Consensus Price Target History for Biostar Pharmaceuticals (NASDAQ:BSPM)

Price Target History for Biostar Pharmaceuticals (NASDAQ:BSPM)

Analysts' Ratings History for Biostar Pharmaceuticals (NASDAQ:BSPM)


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History and Estimates Chart for Biostar Pharmaceuticals (NASDAQ:BSPM)

Earnings by Quarter for Biostar Pharmaceuticals (NASDAQ:BSPM)

Earnings History by Quarter for Biostar Pharmaceuticals (NASDAQ BSPM)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2017Q3 17($0.50)ViewN/AView Earnings Details
11/21/2016Q3 16($0.71)$0.65 millionViewN/AView Earnings Details
8/22/2016Q2($3.12)$0.62 millionViewN/AView Earnings Details
5/23/2016Q1($0.28)$0.80 millionViewN/AView Earnings Details
11/23/2015Q3 15($0.08)$4.21 millionViewN/AView Earnings Details
8/19/2015Q215($0.03)$19.20 million$14.20 millionViewN/AView Earnings Details
5/15/2015Q1 15($0.01)$6.91 millionViewN/AView Earnings Details
8/19/2013Q2 2013($0.06)$8.20 million$14.70 millionViewN/AView Earnings Details
11/19/2012Q312($0.63)$24.78 million$9.97 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biostar Pharmaceuticals (NASDAQ:BSPM)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Biostar Pharmaceuticals (NASDAQ:BSPM)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biostar Pharmaceuticals (NASDAQ BSPM)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Biostar Pharmaceuticals (NASDAQ BSPM)

Source:
DateHeadline
Network-1 Technologies And Other Top Undervalued StocksNetwork-1 Technologies And Other Top Undervalued Stocks
finance.yahoo.com - November 24 at 11:24 AM
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017
www.prnewswire.com - November 20 at 4:23 PM
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017
finance.yahoo.com - November 16 at 12:12 PM
Biostar Pharmaceuticals, Inc. (BSPM) Releases  Earnings ResultsBiostar Pharmaceuticals, Inc. (BSPM) Releases Earnings Results
www.americanbankingnews.com - November 16 at 10:14 AM
Is Biostar Pharmaceuticals Inc’s (BSPM) Balance Sheet Strong Enough To Weather A Storm?Is Biostar Pharmaceuticals Inc’s (BSPM) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - November 3 at 10:28 PM
3 Trending Biotech Stocks To Watch On Monday3 Trending Biotech Stocks To Watch On Monday
finance.yahoo.com - October 9 at 5:32 PM
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency NoticeBiostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
finance.yahoo.com - August 28 at 4:45 PM
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency NoticeBiostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
finance.yahoo.com - August 28 at 4:45 PM
Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) Scheduled to Post Earnings on MondayBiostar Pharmaceuticals, Inc. (NASDAQ:BSPM) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - August 14 at 1:46 AM
EARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q1 Earnings ReportEARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q1 Earnings Report
www.rttnews.com - May 21 at 11:26 AM
BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing RuleBIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
biz.yahoo.com - February 24 at 9:13 PM
BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal OfficersBIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - February 9 at 9:18 PM
Drug Makers Stocks on Investors Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Heron TherapeuticsDrug Makers Stocks on Investors' Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Heron Therapeutics
www.bizjournals.com - January 3 at 10:00 AM
EARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q3 Earnings ReportEARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q3 Earnings Report
www.rttnews.com - November 22 at 3:30 PM
Biostar Pharmaceuticals Inc. (BSPM) Is Spiking To The UpsideBiostar Pharmaceuticals Inc. (BSPM) Is Spiking To The Upside
www.rttnews.com - October 18 at 3:56 PM
Biostar Pharma (BSPM) Enters 425k Share Securities Purchase AgreementBiostar Pharma (BSPM) Enters 425k Share Securities Purchase Agreement
www.streetinsider.com - October 13 at 10:20 AM
Biostar Announces Execution of Agreement for $1.91 Million Registered Direct ...Biostar Announces Execution of Agreement for $1.91 Million Registered Direct ...
www.prnewswire.com - October 12 at 4:13 PM
Biostar Pharma (BSPM) Announces Launch of Easy Breathing Product; Will Target Rhinitis, SinusitisBiostar Pharma (BSPM) Announces Launch of 'Easy Breathing' Product; Will Target Rhinitis, Sinusitis
www.streetinsider.com - October 12 at 8:27 AM
Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and SinusitisBiostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis
www.prnewswire.com - October 12 at 8:27 AM
It was a bad day for stocks, but these three delivered good newsIt was a bad day for stocks, but these three delivered good news
investorplace.com - October 12 at 8:27 AM
Biostar Pharmaceuticals Inc. (BSPM) Surged After New Product AnnouncementBiostar Pharmaceuticals Inc. (BSPM) Surged After New Product Announcement
www.rttnews.com - October 12 at 8:27 AM
Biostar Pharma Skyrockets on New Chinese Product LaunchBiostar Pharma Skyrockets on New Chinese Product Launch
247wallst.com - October 11 at 3:46 PM
BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other EventsBIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - September 23 at 9:05 AM
Biostar Pharma (BSPM) Signs LOI to Acquire Xianyang Yongsheng Health ProductsBiostar Pharma (BSPM) Signs LOI to Acquire Xianyang Yongsheng Health Products
www.streetinsider.com - September 22 at 4:07 PM
Biostar Pharmaceuticals Inc. (BSPM) Is Up Sharply In Early TradeBiostar Pharmaceuticals Inc. (BSPM) Is Up Sharply In Early Trade
www.rttnews.com - September 21 at 8:31 AM
Mid-Morning Market Update: Markets Open Higher; Best Buy Beats Q2 ExpectationsMid-Morning Market Update: Markets Open Higher; Best Buy Beats Q2 Expectations
www.benzinga.com - August 23 at 4:03 PM
EARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q2 Earnings ReportEARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q2 Earnings Report
www.rttnews.com - August 23 at 4:02 PM
BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersBIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - June 13 at 5:02 PM
Biostar Pharmaceuticals Inc. (BSPM) Has Jumped To Nearly A 2-Month HighBiostar Pharmaceuticals Inc. (BSPM) Has Jumped To Nearly A 2-Month High
www.rttnews.com - June 8 at 4:29 PM

Social Media

Financials

Chart

Biostar Pharmaceuticals (NASDAQ BSPM) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.